Korro Bio, Inc.
KRRO
$10.18
-$0.90-8.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -20.31% | 181.46% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -20.31% | 181.46% | -- | -- | -- |
| Cost of Revenue | -15.78% | 5.40% | -29.51% | -14.39% | -0.51% |
| Gross Profit | 15.37% | 2.59% | 38.07% | 22.99% | 8.72% |
| SG&A Expenses | -10.70% | -7.81% | -8.70% | -0.86% | 3.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.66% | -0.47% | 6.38% | 14.42% | 16.76% |
| Operating Income | 13.32% | 4.97% | 1.32% | -7.57% | -11.15% |
| Income Before Tax | -29.19% | -39.77% | -0.62% | -7.04% | -7.66% |
| Income Tax Expenses | 490.32% | 351.77% | 173.68% | 102.13% | 181.82% |
| Earnings from Continuing Operations | -29.84% | -40.30% | -0.69% | -7.10% | -7.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.84% | -40.30% | -0.69% | -7.10% | -7.75% |
| EBIT | 13.32% | 4.97% | 1.32% | -7.57% | -11.15% |
| EBITDA | 13.23% | 5.98% | 3.08% | -6.48% | -11.00% |
| EPS Basic | -23.65% | -32.88% | 21.05% | 86.95% | 93.07% |
| Normalized Basic EPS | 15.86% | 6.73% | 21.12% | 86.96% | 93.07% |
| EPS Diluted | -23.65% | -32.88% | 21.05% | 86.95% | 93.07% |
| Normalized Diluted EPS | 15.86% | 6.73% | 21.12% | 86.96% | 93.07% |
| Average Basic Shares Outstanding | 7.44% | 5.34% | 18.80% | 65.87% | 167.15% |
| Average Diluted Shares Outstanding | 7.44% | 5.34% | 18.80% | 65.87% | 167.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |